Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion

PHASE3RecruitingINTERVENTIONAL
Enrollment

1,060

Participants

Timeline

Start Date

August 8, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Acute Ischemic Stroke
Interventions
DRUG

The methylprednisolone sodium succinate

Patients will receive intra-arterial methylprednisolone sodium succinate 40mg immediately after the recanalization from thrombectomy in anterior circulation large vessel occlusion. Then, intravenous administration with methylprednisolone sodium succinate 2mg/kg in the next 3 days.

DRUG

Placebo

The placebo group patients will receive intra-arterial and intravenous sterile water for injection.

Trial Locations (1)

710038

RECRUITING

Tangdu Hospital, Xi'an

All Listed Sponsors
collaborator

The First people's hospital of Xian Yang

UNKNOWN

collaborator

First People's Hospital Of Tianshui

UNKNOWN

collaborator

XD Group Hospital

UNKNOWN

collaborator

Xi'an Aerospace General Hospital

UNKNOWN

collaborator

First Affiliated Hospital of Chengdu Medical College

OTHER

lead

Tang-Du Hospital

OTHER